Regulation of Insulin and Leptin Signaling by Muscle Suppressor of Cytokine Signaling 3 (SOCS3)

Skeletal muscle resistance to the key metabolic hormones, leptin and insulin, is an early defect in obesity. Suppressor of cytokine signaling 3 (SOCS3) is a major negative regulator of both leptin and insulin signaling, thereby implicating SOCS3 in the pathogenesis of obesity and associated metabolic abnormalities. Here, we demonstrate that SOCS3 mRNA expression is increased in murine skeletal muscle in the setting of diet-induced and genetic obesity, inflammation, and hyperlipidemia. To further evaluate the contribution of muscle SOCS3 to leptin and insulin resistance in obesity, we generated transgenic mice with muscle-specific overexpression of SOCS3 (MCK/SOCS3 mice). Despite similar body weight, MCK/SOCS3 mice develop impaired systemic and muscle-specific glucose homeostasis and insulin action based on glucose and insulin tolerance tests, hyperinsulinemic-euglycemic clamps, and insulin signaling studies. With regards to leptin action, MCK/SOCS3 mice exhibit suppressed basal and leptin-stimulated activity and phosphorylation of alpha2 AMP-activated protein kinase (α2AMPK) and its downstream target, acetyl-CoA carboxylase (ACC). Muscle SOCS3 overexpression also suppresses leptin-regulated genes involved in fatty acid oxidation and mitochondrial function. These studies demonstrate that SOC3 within skeletal muscle is a critical regulator of leptin and insulin action and that increased SOCS may mediate insulin and leptin resistance in obesity.

[1]  J. Flier,et al.  Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells. , 2006, Cell metabolism.

[2]  V. D’Agati,et al.  HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN , 2005, AIDS.

[3]  Zhenggang Yang,et al.  Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance. , 2011, Endocrinology.

[4]  L. Heilbronn,et al.  Toll-like receptor 4 modulates skeletal muscle substrate metabolism. , 2010, American journal of physiology. Endocrinology and metabolism.

[5]  R. Unger.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0870 Minireview: Weapons of Lean Body Mass Destruction: The Role of Ectopic Lipids in the Metabolic Syndrome , 2022 .

[6]  M. White,et al.  SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2* , 2002, The Journal of Biological Chemistry.

[7]  C. Kahn,et al.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. , 1998, Molecular cell.

[8]  Masato Kasuga,et al.  [Obesity and insulin resistance]. , 2009, Nihon rinsho. Japanese journal of clinical medicine.

[9]  G. Steinberg,et al.  AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: Implications for obesity , 2013, Molecular and Cellular Endocrinology.

[10]  B. Kahn,et al.  Leptin signaling in the central nervous system and the periphery. , 2004, Recent progress in hormone research.

[11]  Clifford B. Saper,et al.  Unraveling the central nervous system pathways underlying responses to leptin , 1998, Nature Neuroscience.

[12]  E. Van Obberghen,et al.  SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling* , 2000, The Journal of Biological Chemistry.

[13]  J. Flier,et al.  Identification of SOCS-3 as a potential mediator of central leptin resistance. , 1998, Molecular cell.

[14]  C. Newgard,et al.  Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Kahn,et al.  Diet-induced Obesity Alters AMP Kinase Activity in Hypothalamus and Skeletal Muscle* , 2006, Journal of Biological Chemistry.

[16]  G. Shulman,et al.  Prevention of fat-induced insulin resistance by salicylate. , 2001, The Journal of clinical investigation.

[17]  E. Van Obberghen,et al.  Insulin Induces Suppressor of Cytokine Signaling-3 Tyrosine Phosphorylation through Janus-activated Kinase* , 2001, The Journal of Biological Chemistry.

[18]  J. Flier,et al.  The Role of SOCS-3 in Leptin Signaling and Leptin Resistance* , 1999, The Journal of Biological Chemistry.

[19]  B. Xue,et al.  Transcriptional Synergy and the Regulation of Ucp1 during Brown Adipocyte Induction in White Fat Depots , 2005, Molecular and Cellular Biology.

[20]  Caiying Guo,et al.  Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon cre‐mediated excision , 2000, Genesis.

[21]  T. Ramsay.  Porcine leptin inhibits protein breakdown and stimulates fatty acid oxidation in C2C12 myotubes. , 2003, Journal of animal science.

[22]  M. Eguchi,et al.  Regulation of SOCS-3 expression by leptin and its co-localization with insulin receptor in rat skeletal muscle cells , 2007, Molecular and Cellular Endocrinology.

[23]  J. Flier,et al.  Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. , 2006, Diabetes.

[24]  C. Lobe,et al.  Z/AP, a double reporter for cre-mediated recombination. , 1999, Developmental biology.

[25]  P. Geiger,et al.  Activation of p38 MAP kinase enhances sensitivity of muscle glucose transport to insulin. , 2005, American journal of physiology. Endocrinology and metabolism.

[26]  B. Kemp,et al.  The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. , 2006, The Journal of clinical endocrinology and metabolism.

[27]  J. Flier,et al.  Suppressor of Cytokine Signaling 3 Is a Physiological Regulator of Adipocyte Insulin Signaling* , 2004, Journal of Biological Chemistry.

[28]  F. Haj,et al.  Neuronal Protein Tyrosine Phosphatase 1B Deficiency Results in Inhibition of Hypothalamic AMPK and Isoform-Specific Activation of AMPK in Peripheral Tissues , 2009, Molecular and Cellular Biology.

[29]  C. Kahn,et al.  Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms , 2004, Molecular and Cellular Biology.

[30]  R. Unger.  Lipid overload and overflow: metabolic trauma and the metabolic syndrome , 2003, Trends in Endocrinology & Metabolism.

[31]  Z Trajanoski,et al.  Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. , 1999, The New England journal of medicine.

[32]  C. Newgard,et al.  Direct antidiabetic effect of leptin through triglyceride depletion of tissues. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Okamoto,et al.  Leptin Stimulates Fatty Acid Oxidation and Peroxisome Proliferator-Activated Receptor α Gene Expression in Mouse C2C12 Myoblasts by Changing the Subcellular Localization of the α2 Form of AMP-Activated Protein Kinase , 2007, Molecular and Cellular Biology.

[34]  B. Neel,et al.  Protein-tyrosine Phosphatase 1B Expression Is Induced by Inflammation in Vivo* , 2008, Journal of Biological Chemistry.

[35]  Young-Bum Kim,et al.  Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature.

[36]  J. Flier,et al.  Attenuation of leptin and insulin signaling by SOCS proteins , 2006, Trends in Endocrinology & Metabolism.

[37]  G. Heigenhauser,et al.  Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. , 2002, American journal of physiology. Endocrinology and metabolism.

[38]  Kohjiro Ueki,et al.  Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  L. Orci,et al.  Combined Leptin Actions on Adipose Tissue and Hypothalamus Are Required to Deplete Adipocyte Fat in Lean Rats , 2006, Journal of Biological Chemistry.

[40]  R. Coleman,et al.  Leptin opposes insulin's effects on fatty acid partitioning in muscles isolated from obese ob/obmice. , 1999, American journal of physiology. Endocrinology and metabolism.

[41]  J. Fisher,et al.  Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin. , 2002, American journal of physiology. Endocrinology and metabolism.

[42]  G. Steinberg,et al.  Development of leptin resistance in rat soleus muscle in response to high-fat diets. , 2000, American journal of physiology. Endocrinology and metabolism.

[43]  C. Kahn,et al.  Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. , 2000, Molecular cell.

[44]  B. Xue,et al.  Genetic variability affects the development of brown adipocytes in white fat but not in interscapular brown fats⃞ Published, JLR Papers in Press, October 14, 2006. , 2007, Journal of Lipid Research.

[45]  Sironi,et al.  Insulin: new roles for an ancient hormone , 1999, European journal of clinical investigation.

[46]  Petra C. Kienesberger,et al.  Adipose Triglyceride Lipase Deficiency Causes Tissue-specific Changes in Insulin Signaling* , 2009, The Journal of Biological Chemistry.

[47]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[48]  R. Ceddia,et al.  Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis , 2005, International Journal of Obesity.

[49]  B. Xue,et al.  AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues , 2006, The Journal of physiology.

[50]  R. Coleman,et al.  Leptin Directly Alters Lipid Partitioning in Skeletal Muscle , 1997, Diabetes.